Dr. Reddy’s Laboratories Limited, one of India’s leading pharmaceutical companies, announced the allotment of 6,475 equity shares on September 15, 2025, to eligible employees who exercised their stock options under the Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.

The company’s filing with the National Stock Exchange of India (NSE), BSE Limited, New York Stock Exchange (NYSE), and NSE IFSC Ltd. provides details as per Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, ensuring transparency in employee benefit schemes.

The allotted shares have a par value of Re.1 each, were issued at the exercise price of Re.1 per share, and carry no premium. The shares are identical in all respects to existing shares, ensuring equal rights and ranking pari passu with the previously issued equity. Following this allotment, Dr. Reddy’s total paid-up capital stands at 83,46,13,760 equity shares, aggregating to Rs. 83,46,13,760.

Each of the newly allotted shares carries a distinctive number ranging from 834607286 to 834613760 and has been issued in dematerialized form under ISIN INE089A01031. The allotment does not involve any lock-in period and no listing fees are applicable.

Dr. Reddy’s Laboratories emphasized that this issuance follows all regulatory compliance under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as well as SEBI guidelines for Share Based Employee Benefits and Sweat Equity. These regulations ensure transparency and proper disclosure of stock options exercised by employees, reflecting the company’s commitment to governance and compliance.

The ESOP scheme has been an important tool for Dr. Reddy’s to retain and motivate employees, aligning their interests with the company’s growth and performance. By allowing employees to become shareholders, the company strengthens engagement and promotes a culture of ownership.

Historically, Dr. Reddy’s has maintained high standards of disclosure regarding employee stock options. The current allotment is part of the ongoing practice of issuing equity shares under the ESOP scheme, ensuring transparency to investors, stakeholders, and regulators.

Dr. Reddy’s Laboratories Limited, headquartered at Banjara Hills, Hyderabad, continues to operate as a global pharmaceutical leader, with its shares listed across major exchanges including BSE, NSE, NYSE, and NSE IFSC Ltd.. The ESOP allotment demonstrates the company’s focus on employee welfare while complying with all corporate governance standards.

The company secretary, K. Randhir Singh, responsible for compliance, signed off the disclosure, reinforcing the accuracy and authenticity of the information shared with stock exchanges.

The Upcoming IPOs in this week and coming weeks are Karbonsteel Engineering, Taurian MPS, L. T. Elevator, Galaxy Medicare, Airfloa Rail Technology, Dev Accelerator, Jay Ambe Supermarkets, Urban Company, Shringar House of Mangalsutra, .

The Current active IPO are Nilachal Carbo Metalicks, Krupalu Metals, Vashishtha Luxury Fashion, Sharvaya Metals, Vigor Plast India, Austere Systems.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.